2021. Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s16. DOI:https://doi.org/10.25251/skin.5.supp.16.